API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma
- 1 June 2001
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 120 (7) , 1884-1885
- https://doi.org/10.1053/gast.2001.25305
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Primary gastric B-Cell lymphoma: Results of a prospective multicenter studyGastroenterology, 2000
- API2-MALT1 Chimeric Transcripts Involved in Mucosa-Associated Lymphoid Tissue Type Lymphoma Predict Heterogeneous ProductsThe American Journal of Pathology, 2000
- The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue LymphomasBlood, 1999
- Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infectionThe Lancet, 1995
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993